AH Equity Partners Bio II, L.L.C.
Insider CIK 1725722 · NAUT 10% owner · EQRX 10% owner · SCTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 12,150,003 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 4,131,344 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 2,051,742 | — | $0 | 2,051,742 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 697,650 | — | $0 | 697,650 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 333,333 | $15.00 | $5.00M | 2,385,075 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 4,131,344 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 12,150,003 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 333,333 | $15.00 | $5.00M | 2,385,075 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 697,650 | — | — | 697,650 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 2,051,742 | — | — | 2,051,742 | SEC↗ |
| NAUT Nautilus Biotechnology, In | S Sale | 2026-06-02 | 2026-06-04 | 384,026 | $2.35 | $902.5K | 971,885 | SEC↗ |
| NAUT Nautilus Biotechnology, In | S Sale | 2026-06-02 | 2026-06-04 | 4,615,974 | $2.35 | $10.85M | 11,682,032 | SEC↗ |
| EQRX EQRx, Inc. | U Tender deriv | 2023-11-09 | 2023-11-09 | 1,574,510 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | U Tender deriv | 2023-11-09 | 2023-11-09 | 2,642,897 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | U Tender deriv | 2023-11-09 | 2023-11-09 | 2,401,418 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | U Tender | 2023-11-09 | 2023-11-09 | 19,192,015 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | U Tender | 2023-11-09 | 2023-11-09 | 12,264 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | U Tender | 2023-11-09 | 2023-11-09 | 17,438,465 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | U Tender | 2023-11-09 | 2023-11-09 | 11,433,677 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | U Tender | 2023-11-09 | 2023-11-09 | 5,000,000 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2023-01-01 | 2023-01-04 | 8,246 | — | $0 | 1,574,510 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2023-01-01 | 2023-01-04 | 12,577 | — | $0 | 2,401,418 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2023-01-01 | 2023-01-04 | 13,842 | — | $0 | 2,642,897 | SEC↗ |